GlassScriptPhysician profile
Kathryn E Newlin
NPI 1841696259
$1,576.22
in general payments reported to CMS, 2019-2025
10 companies · $777 in 2025
The $777 reported for 2025 was more than what 80% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $254 · 2022: $79.99 · 2023: $50.85 · 2024: $414 · 2025: $777.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,099 · Education: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,099.03 |
| Education | $143.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $582.34 | 2023-2025 | Enhertu |
| Lilly USA, LLC | $290.85 | 2023-2025 | Verzenio, Jaypirca |
| Seagen INC. | $166.90 | 2021 | |
| Gilead Sciences, INC. | $114.85 | 2024-2025 | Trodelvy |
| Stemline Therapeutics INC. | $100.13 | 2025 | Orserdu |
| Tactile Systems Technology INC | $87.06 | 2021 | |
| Amgen INC. | $79.99 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $65.86 | 2025 | Enhertu |
| Celgene Corporation | $49.84 | 2024 | |
| Merck Sharp & Dohme LLC | $38.40 | 2023-2025 | Lynparza, Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Newlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.